Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)
Latest Information Update: 08 Apr 2022
At a glance
- Drugs Trabectedin (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms E-TRAB
- Sponsors GWT-TUD GmbH
- 01 Apr 2022 Status changed from active, no longer recruiting to completed.
- 20 Dec 2021 Planned End Date changed from 1 Jan 2021 to 31 Dec 2021.
- 20 Dec 2021 Planned primary completion date changed from 1 Jan 2020 to 31 Dec 2021.